Crossmark

Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction

Crossref DOI link: https://doi.org/10.1186/s13148-020-00855-z

Published Online: 2020-05-12

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chang, Shih-Ching

Liew, Phui-Ly

Ansar, Muhamad

Lin, Shih-Yun

Wang, Sheng-Chao

Hung, Chin-Sheng

Chen, Jian-Yu

Jain, Shikha

Lin, Ruo-Kai http://orcid.org/0000-0002-5153-0824
Funding

Funding for this research was provided by:

Ministry of Science and Technology, Taiwan (MOST104-2320-B-038-051-MY3, MOST108-2320-B-038-020)

Ministry of Education (108-5804-001-400)
License Information

Text and Data Mining valid from 2020-05-12

Version of Record valid from 2020-05-12
More Information

Article History

Received: 12 November 2019

Accepted: 23 April 2020

First Online: 12 May 2020

Ethics approval and consent to participate

: The study was approved by the Taipei Medical University-Joint Institutional Review Board and the Institutional Review Board, Taipei Veterans General Hospital. Written informed consent was obtained from all patients.

: Not applicable

: There are no conflicts of interest.

Document is current

Any future updates will be listed below